Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 266 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No intervention/exposures Clear all

Conditions: Hiv, Chlamydia, Gonorrhea
Interventions: all2GETHER; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 16 Years to 34 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Phobias, Claustrophobia, Social Phobia
Interventions: Extinction Training, Low-Level Laser Therapy, Sham Low-Level Laser Therapy; Behavioral · Device
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Ebola Virus Disease
Interventions: Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP), Deuterium Labeled Water; Biological · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Decatur, Georgia • St Louis, Missouri

Conditions: Non-Muscle Invasive Bladder Carcinoma
Interventions: BCG Solution, Best Practice, Cystoscopy, Home Health Encounter, Survey Administration; Biological · Other · Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Fuchs Dystrophy
Interventions: This is an observational study. There is no therapeutic intervention.; Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 55 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Posttraumatic Stress Disorder, Traumatic Brain Injury
Interventions: Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) Therapy; Behavioral
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Tobacco Use, Tobacco Smoking, Tobacco Use Cessation, Smoking, Smoking Cessation, Smoking, Cigarette
Interventions: Motivating Pacifika Against Cigarettes and Tobacco; Behavioral
Lead sponsor: Claremont Graduate University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 278 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Claremont, California • Fullerton, California

Conditions: Traumatic Brain Injury, Cognitive Decline, Vascular Dementia
Interventions: No intervention. This is an observational study.; Other
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 74 Years
Enrollment: 300 participants
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Foot Ulcer
Interventions: Amnio-Maxx; Other
Lead sponsor: Capsicure, LLC; Network
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 12
States / cities: Athens, Alabama • San Diego, California • Coral Gables, Florida + 9 more

Conditions: Environmental Exposure
Interventions: Robotic Vacuum; Other
Lead sponsor: Duke University; Other
Eligibility: Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chemotherapy Induced Peripheral Neuropathy
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS); Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: HIV, STI
Interventions: PrEP discontinuation intervention, Offering of on-demand oral PrEP, Offering of STI PEP, Injectable PrEP; Behavioral · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hoarding Disorder
Interventions: Cognitive Rehabilitation and Exposure/Sorting Treatment (CREST), Exposure Therapy (ET); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Scoliosis; Adolescence, Adolescent Idiopathic Scoliosis, Thoracic Region, Adolescent Idiopathic Scoliosis, Lumbar Region
Interventions: Massage Therapy; Other
Lead sponsor: Cook Children's Health Care System; Other
Eligibility: 7 Years to 19 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Diagnoses Disease
Interventions: ABCD Information, UDS information, Standard (clinical) feedback, Motivational feedback; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 1,849 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: CML, Chronic Phase, CML (Chronic Myelogenous Leukemia, CML - Philadelphia Chromosome, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase
Interventions: Bosutinib, Dasatinib, Imatinib, Nilotinib; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Alcohol Drinking
Interventions: Task-based behavioral intervention; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 21 Years to 35 Years
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Myeloma
Interventions: BT062; Drug
Lead sponsor: Biotest Pharmaceuticals Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 5
States / cities: Atlanta, Georgia • Chicago, Illinois • Boston, Massachusetts + 2 more

Conditions: HIV Infections
Interventions: myDEx, NTHP; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 24 Years · Male only
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Juvenile; Scoliosis, Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis;Congenital, Kyphosis, Spondylolisthesis
Interventions: CBT (SurgeryPal), Education; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Dermatitis, Photoallergic
Interventions: Butenafine HCl 1% (BAY1896425) - Induction Phase, Butenafine HCl 1% (BAY1896425) - Challenge Phase; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Fairfield, New Jersey

Conditions: Colorectal Cancer
Interventions: Multimedia Education, Print Media, Usual and customary waiting room process; Behavioral
Lead sponsor: Trinity Health Of New England; Other
Eligibility: 50 Years to 80 Years
Enrollment: 920 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: Highland Park, Illinois • North Chicago, Illinois • Waukegan, Illinois

Conditions: Asthma
Interventions: High Efficiency Particulate Air Cleaner, Sham air cleaner; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Adrenocortical Adenoma, Endometrial Stromal Sarcomas
Interventions: MRI, CT or ultrasound was permitted if MRI was contraindicated, Dexamethasone Supression Test, Sonogram, Biopsy, BGG492; Procedure · Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Tallahassee, Florida • Baltimore, Maryland • Hoffman, New Jersey + 1 more

Search by objective public record fields.

Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men

Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training

Immunology of Ebola Vaccine

Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder Carcinoma

Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure

3MDR to Treat PTSD With mTBI (3MDR)

Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco

Cognitive and Vascular Functioning Following TBI

Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Customized Approaches for Evaluating and Reducing Chemical Exposures From Home Building Materials

Self-applied taVNS for CIPN

Parrying the Pitfalls of PrEP: Project PEACH

Cognitive Rehab and Exposure Treatment for Hoarding

Massage Therapy After Thoracic or Lumbar Surgery

Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Development of a Tailored HIV Prevention Intervention for Young Men

Digital Health Psychosocial Intervention for Adolescent Spine Surgery Preparation and Recovery

Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants

Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492